S&P 및 Nasdaq 내재가치 문의하기

Quantum BioPharma Ltd. QNTM NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
39/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Quantum BioPharma Ltd. (QNTM) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

애널리스트 추정 주당순이익(EPS) $-3.18 및 매출 $0.00B 다음 회계연도.

주당순이익(EPS) 실적 추이: 2024: 실적 $-12.49 vs 추정 $-3.18 (하회 -292.6%). 2025: 실적 $-8.11 vs 추정 $-8.28 (상회 +2.1%). 애널리스트 정확도: 62%.

EPS 전망 — QNTM

62%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024 Actual –$12.49 vs Est –$3.18 ▼ 74.5% off
2025 Actual –$8.11 vs Est –$8.28 ▲ 2.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

매출 전망 — QNTM

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기